Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue-type plasminogen activator deficiency exacerbates arthritis.

Y H Yang1, P Carmeliet, J A Hamilton

  • 1Department of Medicine, Arthritis and Inflammation Research Centre, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia. yuan.yang@med.monash.edu.au

Journal of Immunology (Baltimore, Md. : 1950)
|July 7, 2001
PubMed
Summary

Plasminogen activators (PAs), including tissue-type PA and urokinase PA, protect against inflammatory arthritis. Gene-deficient mice lacking these PAs showed worsened arthritis, indicating their crucial role in managing joint inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probable Encephaloid Disease of the Left Kidney.

Medical examiner (Chicago, Ill.)·2023
Same author

Suppression of Menses, with Good Health.

Medical examiner (Chicago, Ill.)·2023
Same author

Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice.

Osteoarthritis and cartilage·2020
Same author

Development of interest and enjoyment in adolescence. Part I. Attentional capacities.

Journal of youth and adolescence·2013
Same author

Development of interest and enjoyment in adolescence. Part II. Boredom and psychopathology.

Journal of youth and adolescence·2013
Same author

Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling.

British journal of pharmacology·2013

Area of Science:

  • Biomedical Science
  • Immunology
  • Rheumatology

Background:

  • Inflammatory joint diseases like rheumatoid arthritis involve fibrin deposition, cell migration, and tissue remodeling.
  • Plasminogen activators (PAs), specifically tissue-type PA (t-PA) and urokinase PA, are linked to these inflammatory processes but their exact roles are unclear.

Purpose of the Study:

  • To investigate the roles of t-PA and urokinase PA in inflammatory arthritis using a two-stage mouse model.
  • To determine if PAs play a protective or detrimental role in arthritis development and severity.

Main Methods:

  • Utilized a two-stage arthritis model in gene-deficient mice.
  • Induced arthritis via intraarticular methylated BSA injection followed by systemic IL-1 treatment.
  • Assessed disease severity and fibrin deposition in mice lacking t-PA or urokinase PA.

Related Experiment Videos

Main Results:

  • Absence of either t-PA or urokinase PA exacerbated arthritis induced by methylated BSA alone.
  • Mice deficient in t-PA (t-PA(-/-)) exhibited particularly severe disease after systemic IL-1 treatment.
  • Fibrin deposition levels correlated with disease severity across experimental conditions.

Conclusions:

  • Both t-PA and urokinase PA appear to have a protective role in inflammatory joint disease.
  • PA-mediated fibrinolysis may be a key mechanism for limiting inflammation and tissue damage in arthritis.
  • Further research into PA function could reveal therapeutic targets for rheumatoid arthritis.